Business Context and Reporting Period
Company: RELMADA THERAPEUTICS, INC. (RLMD)
Filing Type: Form 8-K (Current Report)
Date of Report: May 8, 2025
Reporting Period: The filing addresses events occurring on May 8, 2025, regarding the change of the company's independent registered public accounting firm.
Key Financial Metrics
This filing does not contain specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on the administrative change of the external auditor.
Material Changes Versus Prior Period
- Accountant Resignation: Marcum LLP was dismissed as the independent registered public accounting firm on May 8, 2025. This action was taken because CBIZ CPAs P.C. acquired Marcum's attest business on November 1, 2024.
- Accountant Engagement: CBIZ CPAs was engaged as the new independent registered public accounting firm for the fiscal year ending December 31, 2025, effective May 8, 2025.
- Audit History: Marcum's audit reports for fiscal years ended December 31, 2024, and 2023, did not contain adverse opinions or disclaimers. However, the reports included an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.
- Disagreements: There were no disagreements or reportable events between the Company and Marcum during the fiscal years ended December 31, 2024 and 2023, or through May 8, 2025.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms that the change in auditors was approved by the Company's audit committee and was a direct result of the acquisition of Marcum by CBIZ CPAs. Marcum LLP has provided a letter agreeing with the statements made in this report regarding the dismissal.
Risks and Contingencies: The filing explicitly notes that prior audit reports included an explanatory paragraph relating to substantial doubt about the Company's ability to continue as a going concern. No new risks or contingencies were disclosed in this specific filing.
Important Facts for Investor Verification
- Verify the status of the "substantial doubt about going concern" noted in the 2023 and 2024 audit reports to understand current liquidity risks.
- Confirm the transition timeline and any potential delays in the 2025 audit process due to the change from Marcum to CBIZ CPAs.
- Review the letter from Marcum LLP (Exhibit 16.1) to ensure no undisclosed disagreements existed prior to dismissal.
- Monitor future filings for the first financial statements audited by CBIZ CPAs to assess any changes in accounting treatment or disclosure.